Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
Open Access
- 1 October 1995
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 96 (4) , 2043-2050
- https://doi.org/10.1172/jci118252
Abstract
Nephrogenic diabetes insipidus (NDI) is most often an X-linked disorder in which urine is not concentrated due to renal resistance to arginine vasopressin. We recently identified four vasopressin type 2 receptor gene mutations in unrelated X-linked NDI families, including R143P, delta V278, R202C, and 804insG. All these mutations reduced ligand binding activity to < 10% of the normal without affecting mRNA accumulation. To elucidate whether the receptors are expressed on the cell surface, we analyzed biosynthesis and localization of tagged or untagged receptors stably expressed in Chinese hamster ovary (CHO) cells, using two antibodies directed against distinct termini. Whole-cell and surface labeling studies revealed that the R202C clone had both surface-localized (50-55 kD) and intracellular proteins (40 and 75 kD), similar to the wild-type AVPR2 clone, whereas the R143P and delta V278 clones lacked the surface receptors, despite relatively increased intracellular components. The 804insG mutant cell produced no proteins despite an adequate mRNA level. Immunofluorescence staining confirmed that the R202C mutant reaches the cell surface, whereas the R143P and delta V278 mutants are retained within the cytoplasmic compartment. Thus, R202C, R143P/delta V278, and 804insG result in three distinct phenotypes, that is, a simple binding impairment at the cell surface, blocked intracellular transport, and ineffective biosynthesis or/and accelerated degradation of the receptor, respectively, and therefore are responsible for NDI. This phenotypic classification will help understanding of molecular pathophysiology of this disorder.Keywords
This publication has 35 references indexed in Scilit:
- Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidusKidney International, 1995
- Two Vasopressin Type 2 Receptor Gene Mutations R143P and ΔV278 in Patients with Nephrogenic Diabetes Insipidus Impair Ligand Binding of the ReceptorBiochemical and Biophysical Research Communications, 1995
- The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin.Journal of Biological Chemistry, 1994
- Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidusHuman Molecular Genetics, 1994
- Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidusHuman Molecular Genetics, 1994
- An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.Molecular Endocrinology, 1994
- Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats.Circulation Research, 1990
- Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidusKidney International, 1989
- Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes InsipidusNew England Journal of Medicine, 1988
- The structure of an antigenic determinant in a proteinCell, 1984